Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2012
11/27/2012CA2540559C Expression of biologically active polypeptides in duckweed
11/27/2012CA2488404C Genes and polypeptides relating to human colon cancers
11/27/2012CA2449157C Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties
11/27/2012CA2416545C Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia
11/27/2012CA2413151C Host cells containing multiple integrating vectors
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/22/2012WO2012159079A1 Assay to determine lrrk2 activity in parkinson's disease
11/22/2012WO2012158989A2 Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
11/22/2012WO2012158948A1 Human immunodeficiency virus neutralizing antibodies adn methods of use thereof
11/22/2012WO2012158704A1 Fgfr1 agonists and methods of use
11/22/2012WO2012158657A1 Therapeutic anti-igf1r combinations
11/22/2012WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/22/2012WO2012158445A1 Compositions and methods for the alteration of xlhed phenotypes
11/22/2012WO2012158123A1 Compounds and methods for treating insulin resistance syndrome
11/22/2012WO2012157484A1 Monoclonal antibody and inspection device using same
11/22/2012WO2012156975A1 COMBINATIONS OF ANTI ErbB ANTIBODIES FOR THE TREATMENT OF CANCER
11/22/2012WO2012156532A1 Anti-human-her3 antibodies and uses thereof
11/22/2012WO2012156505A1 Antibodies against tropomyosin-related kinase b receptors
11/22/2012WO2012156455A1 Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms
11/22/2012WO2012156452A1 Method for detecting infections
11/22/2012WO2012156430A1 Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
11/22/2012WO2012156330A1 Rbm3 in bladder cancer
11/22/2012WO2012156309A1 Antibodies against her3
11/22/2012WO2012156219A1 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
11/22/2012WO2012156018A1 Antibodies for treatment of cancer expressing claudin 6
11/22/2012WO2012155819A1 Hbv specific antibody
11/22/2012WO2012131004A3 Antibodies directed against icos and uses thereof
11/22/2012WO2012122533A3 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
11/22/2012WO2012109538A3 Surrogates of post-translationally modified proteins and uses thereof
11/22/2012WO2012092374A9 Express humanization of antibodies
11/22/2012WO2012059882A3 Engineered polypeptide conjugates and methods for making thereof using transglutaminase
11/22/2012WO2011146514A3 Rapid isolation of monoclonal antibodies from animals
11/22/2012US20120297507 Method
11/22/2012US20120297502 Method for improving plant tolerance to environmental stress
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120296070 Recurrent gene fusions in prostate cancer
11/22/2012US20120296069 Liquid formulations for long-acting erythropoietin conjugate
11/22/2012US20120295990 Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay
11/22/2012US20120295287 Preparing hapten-specific antibodies and their application for immunodiagnostics and research
11/22/2012US20120295282 Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
11/22/2012US20120294951 Use of goat serum for veterinary treatment
11/22/2012US20120294884 Methods of blocking tissue destruction by autoreactive t cells
11/22/2012US20120294883 Oligomeric receptor ligand pair member complexes
11/22/2012US20120294874 Method for Producing T Cell Receptor-Like Monoclonal Antibodies and Uses Thereof
11/22/2012US20120294873 ANTI-EpCAM IMMUNOGLOBULINS
11/22/2012US20120294870 Compositions and methods for diagnosis and treatment of tumors
11/22/2012US20120294865 Integrin Alpha-2 Binding Agents and Use Thereof to Inhibit Cancer Cell Proliferation
11/22/2012US20120294864 Endoglin Antibodies
11/22/2012US20120294862 Antagonists of il-17a, il-17f, and il-23p19
11/22/2012US20120294861 Fgfr1 agonists and methods of use
11/22/2012US20120294856 Compounds inhibiting cd95 signaling for the treatment of pancreatic cancer
11/22/2012US20120294848 IGE CH3 Peptide Vaccine
11/22/2012US20120294847 Immunoglobulin reduced in thrombogenic agents and preparation thereof
11/22/2012US20120294800 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies
11/22/2012US20120294799 Anti-tem1 antibodies and uses thereof
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012US20120294796 Antibodies Reactive with B7-H3 and Uses Thereof
11/22/2012CA2840175A1 Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferation
11/22/2012CA2836468A1 Human immunodeficiency virus neutralizing antibodies and methods of use thereof
11/22/2012CA2836322A1 Immunoglobulin reduced in thrombogenic agents and preparation thereof
11/22/2012CA2835738A1 Use of anti-cd19 maytansinoid immunoconjugate antibody for the treatment of b-cell malignancies symptoms
11/22/2012CA2834907A1 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
11/22/2012CA2834879A1 Fgfr1 agonists and methods of use
11/22/2012CA2834653A1 Rbm3 in bladder cancer
11/22/2012CA2834566A1 Therapeutic anti-igf1r combinations
11/22/2012CA2832174A1 Antibodies for treatment of cancer expressing claudin 6
11/21/2012EP2524964A1 Antibody specific to activated egfr
11/21/2012EP2524929A1 Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of CD19+ B-cell malignancies syptoms
11/21/2012EP2524928A1 RBM3 in bladder cancer
11/21/2012EP2524699A1 Vaccine preparation containing trifunctional antibodies with antigen immunogenicity enhancer properties
11/21/2012EP2524233A2 Compositions and methods for detecting cancer
11/21/2012EP2524041A1 Recombinant antibody vector
11/21/2012EP2523976A1 Biomarkers of immunomodulatory effects in humans treated with anti-cd200 antibodies
11/21/2012EP2523975A1 Bacterial host strain comprising a mutant spr gene and a wild-type tsp gene
11/21/2012EP2523974A1 Wnt-binding agents and uses thereof
11/21/2012EP2523973A1 Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof
11/21/2012EP2523972A1 Multivalent antibodies
11/21/2012EP2523688A1 Antibody formulation and therapeutic regimens
11/21/2012EP2523687A1 Methods for diagnosis and treatment of cutaneous t cell lymphomas
11/21/2012EP2523686A2 Liver targeting domain antibodies
11/21/2012EP2523683A1 Fusion proteins for delivery of erythropoietin to the cns
11/21/2012EP2523682A2 Notch1 binding agents and methods of use thereof
11/21/2012CN1891716B No mitogen activity anti CD3 small molecular antibody designing method
11/21/2012CN1835975B Modified human IGF-1R antibodies
11/21/2012CN102791866A Common light chain mouse
11/21/2012CN102791739A Modulators of hepatocyte growth factor activator
11/21/2012CN102791738A Antibodies binding preferentially human CSF1R extracellular domain 4 and their use
11/21/2012CN102791737A Antibodies that specifically bind to the EPHA2 receptor
11/21/2012CN102791736A Antagonists of Dsg2 for treatment of cancer
11/21/2012CN102791735A Monoclonal antibodies to progastrin and their uses
11/21/2012CN102791734A Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza a viruses
11/21/2012CN102791733A Anti-HSV antibody
11/21/2012CN102791732A Milk derived antigen specific antibodies for inducing an adaptive immune response, methods of preparation and uses thereof
11/21/2012CN102791726A Method for purifying immunoglobulin solutions
11/21/2012CN102791293A Liver targeting molecules
11/21/2012CN102786598A Anti-ERCC1 monoclonal antibody 4F9 and application
11/21/2012CN102786597A Anti ERCC1 monoclonal antibody 2E12 and application
11/21/2012CN102786596A Single-chain antibody KGH-R1-ScFv for resisting p21Ras protein and application thereof
11/21/2012CN102786595A Anti-CD5 monoclonal antibody and purpose thereof
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 1494